Matches in Wikidata for { <http://www.wikidata.org/entity/Q73045798> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- Q73045798 description "article scientifique publié en 1999" @default.
- Q73045798 description "artículu científicu espublizáu n'ochobre de 1999" @default.
- Q73045798 description "im Oktober 1999 veröffentlichter wissenschaftlicher Artikel" @default.
- Q73045798 description "scientific article published on 01 October 1999" @default.
- Q73045798 description "wetenschappelijk artikel" @default.
- Q73045798 description "наукова стаття, опублікована в жовтні 1999" @default.
- Q73045798 name "Analytical and clinical performance characteristics of Hybritech's Tandem-R free PSA assay during a large multicenter clinical trial to determine the clinical utility of percentage of free prostate-specific antigen" @default.
- Q73045798 name "Analytical and clinical performance characteristics of Hybritech's Tandem-R free PSA assay during a large multicenter clinical trial to determine the clinical utility of percentage of free prostate-specific antigen" @default.
- Q73045798 type Item @default.
- Q73045798 label "Analytical and clinical performance characteristics of Hybritech's Tandem-R free PSA assay during a large multicenter clinical trial to determine the clinical utility of percentage of free prostate-specific antigen" @default.
- Q73045798 label "Analytical and clinical performance characteristics of Hybritech's Tandem-R free PSA assay during a large multicenter clinical trial to determine the clinical utility of percentage of free prostate-specific antigen" @default.
- Q73045798 prefLabel "Analytical and clinical performance characteristics of Hybritech's Tandem-R free PSA assay during a large multicenter clinical trial to determine the clinical utility of percentage of free prostate-specific antigen" @default.
- Q73045798 prefLabel "Analytical and clinical performance characteristics of Hybritech's Tandem-R free PSA assay during a large multicenter clinical trial to determine the clinical utility of percentage of free prostate-specific antigen" @default.
- Q73045798 P1433 Q73045798-E786B110-4E45-4459-9B18-49986F98D119 @default.
- Q73045798 P1476 Q73045798-66FAE693-08BE-496B-8F49-69E617A8CB75 @default.
- Q73045798 P2093 Q73045798-0174FC62-D8D5-4873-8F3D-0D1DBF7D3412 @default.
- Q73045798 P2093 Q73045798-0D860EF7-76AD-4E9C-BA40-5625D96C15C4 @default.
- Q73045798 P2093 Q73045798-0F88B710-B307-47DB-9483-C96F9E363EE3 @default.
- Q73045798 P2093 Q73045798-15FA0415-2550-4AD7-B332-65B3993EFE56 @default.
- Q73045798 P2093 Q73045798-1FF1095C-35B5-403A-9D68-473DFA2E2488 @default.
- Q73045798 P2093 Q73045798-428BB3BD-C7C6-4936-802E-E66AEE8E2ABB @default.
- Q73045798 P2093 Q73045798-5C102D96-3489-425F-B3A7-8B39EE155301 @default.
- Q73045798 P2093 Q73045798-5F6FFAFC-D3E6-4756-8322-997CC2974C78 @default.
- Q73045798 P2093 Q73045798-63E24D40-C9EB-4E3E-8C5D-0060385D8AFB @default.
- Q73045798 P2093 Q73045798-69395332-3DB8-4D4E-B511-D4F5C535DF72 @default.
- Q73045798 P2093 Q73045798-79BCC91F-B9C9-4A6D-BE14-144CEA812F50 @default.
- Q73045798 P2093 Q73045798-7A13C2F0-61BD-4326-B486-0CFD089CE25D @default.
- Q73045798 P2093 Q73045798-804CE7F8-A740-46D7-ACBC-D6BF890C4D0D @default.
- Q73045798 P2093 Q73045798-828C1AE4-63C7-477B-80E9-EA3E743A5C9B @default.
- Q73045798 P2093 Q73045798-8861260A-715D-4C3E-A376-A808EDE39BA6 @default.
- Q73045798 P2093 Q73045798-8F0295E7-63AE-4A7B-A4A9-18FB715E701D @default.
- Q73045798 P2093 Q73045798-A50D6F77-9A98-429B-9D1D-914A0381BE5F @default.
- Q73045798 P2093 Q73045798-B7B585DB-0B59-4A9A-B03F-D0DDEAA0F958 @default.
- Q73045798 P2093 Q73045798-CC4F3A6D-F93C-4CFE-A6B0-B0B5E4F3A01C @default.
- Q73045798 P2093 Q73045798-D43A0D3C-A76E-47A0-A2B1-6C9C730F1FDD @default.
- Q73045798 P2093 Q73045798-D7A882B0-F5C4-4183-834E-CAAE9CA8E964 @default.
- Q73045798 P2093 Q73045798-E76E8026-9703-405A-BA18-EB3E27258910 @default.
- Q73045798 P2093 Q73045798-F80718E9-0CD8-4E11-B0FD-09EE2BCB207C @default.
- Q73045798 P304 Q73045798-9AAAD657-400D-4B25-8D38-8127C3E1A2F6 @default.
- Q73045798 P31 Q73045798-3271299C-3DC7-4808-99C4-70EAB3F49EFC @default.
- Q73045798 P407 Q73045798-87DBAC8A-C22A-4CD8-9357-A98C859DABC1 @default.
- Q73045798 P433 Q73045798-B536592E-35AB-4AB5-BE37-E0DAC411292D @default.
- Q73045798 P478 Q73045798-AF40DB41-08C2-412B-AF15-F0E6AB545B5C @default.
- Q73045798 P577 Q73045798-246458CE-32C5-406B-BC6F-7F1B71EACFDF @default.
- Q73045798 P698 Q73045798-6C711905-997D-43D8-82B6-E11CA6E509E4 @default.
- Q73045798 P921 Q73045798-59E988B6-557D-414E-A515-AF4CC62D3713 @default.
- Q73045798 P698 10508137 @default.
- Q73045798 P1433 Q849687 @default.
- Q73045798 P1476 "Analytical and clinical performance characteristics of Hybritech's Tandem-R free PSA assay during a large multicenter clinical trial to determine the clinical utility of percentage of free prostate-specific antigen" @default.
- Q73045798 P2093 "C A Kelley" @default.
- Q73045798 P2093 "C Grudzien" @default.
- Q73045798 P2093 "D D'Agostino" @default.
- Q73045798 P2093 "D J Lamb" @default.
- Q73045798 P2093 "D L Woodrum" @default.
- Q73045798 P2093 "D N Kaske" @default.
- Q73045798 P2093 "D W Chan" @default.
- Q73045798 P2093 "D W Golightly" @default.
- Q73045798 P2093 "G H Gasior" @default.
- Q73045798 P2093 "G Layco" @default.
- Q73045798 P2093 "J Beck" @default.
- Q73045798 P2093 "J McBride" @default.
- Q73045798 P2093 "J Ritchey" @default.
- Q73045798 P2093 "K G Loveland" @default.
- Q73045798 P2093 "K R Bray" @default.
- Q73045798 P2093 "M H Wener" @default.
- Q73045798 P2093 "M J Tanasijevic" @default.
- Q73045798 P2093 "M K Ota" @default.
- Q73045798 P2093 "N Lott" @default.
- Q73045798 P2093 "P C Southwick" @default.
- Q73045798 P2093 "P Daum" @default.
- Q73045798 P2093 "R E Henkin" @default.
- Q73045798 P2093 "T L Ratliff" @default.
- Q73045798 P304 "1863-1865" @default.
- Q73045798 P31 Q13442814 @default.
- Q73045798 P407 Q1860 @default.
- Q73045798 P433 "10" @default.
- Q73045798 P478 "45" @default.
- Q73045798 P577 "1999-10-01T00:00:00Z" @default.
- Q73045798 P698 "10508137" @default.
- Q73045798 P921 Q6934595 @default.